Moderna shares jump 10% after the possibility of having a new vaccine for Omicron in early 2022

The share of Moderna Inc jumped 10.1% in pre-conference trading on Monday after rising 20.7% in the previous session, amid hopes for the rapid development of a new vaccine for this Omicron variant.

The company’s stock rallied on Friday as the company announced it would “immediately promote” a booster dose of the vaccine.

On Sunday, Moderna’s medical director Paul Burton told the BBC that in the next two weeks he would be aware of the current vaccine’s ability to provide protection against the new variant.

“If we have to make a completely new vaccine, I think it will come in early 2022, before it really becomes available in large quantities,” he added.

Meanwhile, Moderna CEO Stefan Bancell said data on the effectiveness of the Omicron variant of the vaccines would be known in 2 to 6 weeks.

In an interview with CNBC, he also said that he believes that the Omicron variant is highly contagious, while he believes that the measures taken by many governments will slow down the transmission of the virus.

.

Source From: Capital

Donald Westbrook

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.